PF-Atlas › Clinical Trials › NCT06238856
Single Dose Escalation Study of TR02 in Participants With Cystic Fibrosis Having Chronic Infections of Pseudomonas Aeruginosa
SLIT™ Amikacin · Phase 1
Registry ID
NCT06238856
Phase
Phase 1
Status
Completed
Drug / intervention
SLIT™ Amikacin
Sponsor
Insmed Incorporated
Start
2004-05-12
About this trial
SLIT™ Amikacin is evaluated in NCT06238856, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Insmed Incorporated. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT06238856 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.